DSMOME afholder symposium sammen med Biopeople og Bioneer: Biomarkers and the implementation of personalized Medicine to the Clinic

1st Danish Symposium on Biomarkers and the Implementation of Personalized Medicine to the Clinic

On January 13th, 2015 the 1st Danish Symposium on Biomarkers and the Implementation of Personalized Medicine to the Clinic is taking place at the Panum Institute in Copenhagen. The symposium is co-hosted by the Danish Society of Molecular Medicine, Biopeople, and Bioneer and the speakers will discuss a range of disciplines within the area of translational medicine.

“With this symposium we are looking to establish a discussion forum on where we are lacking biomarkers to improve patient stratification and how we can use existing technologies and new platforms in the future both to implement personalized medicine in the clinic but also to aid in future drug development and drug/diagnostic co-development. Through the Biomarker Network Initiation following up on this symposium we will define workshops dealing with these challenges,” explains Kim Holmstrøm, R&D Manager, Molecular Detection, Bioneer.

 

Place: Hannover Auditotium, Panum Institute, University of Copenhagen, Blegdamsvej 3B, 2200 København N 
Map of Panum Institute - Hannover Auditorium


Date: 
Tuesday 13 January 2015


Time:
09.00-16.30


Registration: Online registration here - DEADLINE is December 15 2014


Program

9.00 – 9.30: Registration & Coffee

9.30 – 9.35: Welcome by Kim Holmstrøm, Bioneer

9.35 – 11.05: Setting the scene for translating biomarkers to the clinic – Chair Kim Holmstrøm

  • Olli Kallioniemi, Institute for Molecular Medicine Finland: ‘How Personalized are we now? – Precision Medicine a new concept’
  • Ulrik Lassen, The Finsen Centre: ‘Where are we lacking biomarkers to improve treatment efficiency?’
  • Estrid Høgdall, Herlev Hospital: ‘What role do the biobanks play?’

11.05 – 11.30: Networking & Coffee

11.30 – 13.00: Drug diagnostic co‐development – Chair TBA

  • Michael K. Bauer, Genmab: ‘How does the pharmaceutical industry employ biomarkers in the drug development process?’
  • Henrik Winther, DAKO: ‘Companion Diagnostics/Drug Diagnostic co‐development’
  • Peter Buhl Jensen, Medical Prognosis Institute: ‘Drug response prediction using gene expression profiling’

13.00 – 13.45: Networking & Sandwiches

13.45 – 15.15: Technology platforms – Chair TBA

  • Lars Bolund, Aarhus University: ‘Next generation sequencing technologies for high‐content mutation screening’
  • Finn Cilius Nielsen, Copenhagen University Hospital  ‘Gene expression profiling technologies – state‐of‐the‐art’
  • Boye Schnack Nielsen, Bioneer: ‘Molecular histology – introducing the morphological dimension’

15.15 – 15.45: Wrap‐up and Biomarker Network Initiation – Moderator Elias Zafirakos, Biopeople

  • Defining upcoming Workshops within the Biomarker Network

15.45 – 16.30: Signing up for Network + Beer & Snack networking  

 

Download program here

Nyheder

DSMOME afholder årsmøde nr. 3 den 30. november 2016 i København
Læs om mødet her

DSMOME afholder seminar nr. 6 om "Bringing genomes to the bedside - precision medicine in action" den 25. maj 2016 i Aarhus
Mere information her

DSMOME afholder årsmøde nr. 2 den 28. oktober 2015 i København
Læs om mødet her

BilerChildrenLeg og SpilAutobranchen